Continuous hemodiafiltration in pediatric critical care patients

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 5, 2004, Pages 390-397

  Shiga, Hidetoshi ^a   Hirasawa, Hiroyuki ^a   Oda, Shigeto ^a   Matsuda, Kenichi ^a   Ueno, Hirokazu ^a   Nakamura, Masataka ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticoagulants; Continuous hemodiafiltration; Critical care; Hypothermia; Pediatric patients

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; NAFAMSTAT MESILATE;

ADOLESCENT; ARTICLE; BODY SIZE; BODY TEMPERATURE; CHILD; CHILDHOOD DISEASE; CONTINUOUS HEMODIAFILTRATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOFILTRATION; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SURVIVAL RATE; THERMOREGULATION;

ADOLESCENT; ANTICOAGULANTS; BODY SIZE; BODY TEMPERATURE; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; GUANIDINES; HEMODIAFILTRATION; HEMODYNAMIC PROCESSES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PEDIATRICS;

EID: 10044222206     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00174.x     Document Type: Article

References (20)

1. Hirasawa H, Sugai T, Ohtake Y et al. Continuous hemofiltration in the treatment of anuric multiple organ failure. Artif Organs 1990;14:117-9.
2. Hirasawa H, Sugai T et al. Continuous hemofiltration and hemodiafiltration in the management of multiple organ failure. In: Sieberth, HG, Mann, H, Stummvoll, HK, eds. Contributions to Nephrology. Basel: Karger, 1991;42-6.
3. Dunham CM. Clinical impact of continuous renal replacement therapy on multiple organ failure. World J Surg 2001;25:669-76.
4. Sadahiro T, Hirasawa H, Oda S et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med 2001;29:1386-92.
5. Matsuda K, Hirasawa H, Oda S et al. Current topics on cytokine removal technologies. Ther Apher 2001;5:306-14.
6. Brittinger WD, Walker G, Twittenhoff WD et al. Blood access for hemodialysis in children. Pediatr Nephrol 1997;11:87-95.
7. Golej J, Kitzmueller E, Hermon M et al. Low-Volume peritoneal dialysis in 116 neonatal and paediatric critical care patients. Eur J Pediatr 2002;161:385-9.
8. Leonard MB, Donaldson LA, Ho M, Geary DF. A prospective cohort study of incident maintenance dialysis in children: An NAPRTC study. Kidney Int 2003;63:744-55.
9. Kohli HS, Bhalla D, Sud K et al. Acute peritoneal dialysis in neonates: comparison of two types of peritoneal access. Pediatr Nephrol 1999;13:241-4.
10. Bunchman TE, Maxvold NJ, Kershaw DB et al. Continuous venovenous hemodiafiltration in infants and children. Am J Kidney Dis 1995;25:17-21.
11. Ponikvar R, Kandus A, Urbancic A, Kornhauser AG, Primozic J, Ponikvar JB. Continuous renal replacement therapy and plasma exchange in newborns and infants. Artif Organs 2002;26:163-8.
12. Schaefer F, Straube E, Oh J et al. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 1999;14:910-8.
13. Ellis EN, Pearson D, Belsha CW et al. Use of pump-assisted hemofiltration in children with acute renal failure. Pediatr Nephrol 1997;11:196-200.
14. Sanchez C, Lopez-Herce J, Garcia E et al. Continuous veno-venous renal replacement therapy using a conventional infusion pump. ASAIO J 2001;47:321-4.
15. Blei AT, Olafsson S, Webster S et al. Complication of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;341:157-8.
16. Matsuo T, Kario K, Nakao K et al. Anticoagulation with nafamostat mesylate, a synthetic protease inhibitor, in hemodialysis patients with a bleeding risk. Haemostasis 1993;23:135-41.
17. Ohtake Y, Hirasawa H, Sugai T et al. Nafamoatat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. In: Sieberth, HG, Mann, H, Stummvoll, HK, eds. Contributions to Nephrology. Basel: Karger, 1991;215-7.
18. Spiegel DM, Anderson RJ. Is low-molecular-weight heparin useful for venovenous hemofiltration in the intensive care unit? Crit Care Med 1999;27:2316-7.
19. Kornecki A, Tauman R, Lubetzky R et al. Continuous renal replacement therapy for non-renal indications: experience in children. Isr Med Assoc J 2002;4:345-8.
20. Hirasawa H, Sugai T, Ohtake Y et al. Acute hepatic failure in critical care: Diagnosis and treatment. In: Gullo, A, ed. Anaesthesia, Pain, Intensive Care and Emergency. Trieste: APICE, 1993;651-5.